| Financial Year |
March 31 2023 |
| Monetary Funds |
364,318,288.33 |
| Held-for-trading Financial Assets |
143,049,504.72 |
| Notes Receivable |
210,459,461.40 |
| Accounts Receivable |
508,974,224.49 |
| Advances to Suppliers |
50,486,408.21 |
| Other Receivables |
82,081,509.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
666,651,313.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
68,582,778.48 |
| Total Current Assets |
2,152,061,591.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
7,049,504.85 |
| Fixed Assetes |
548,134,356.36 |
| Under-construction Projects |
2,295,777.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
67,653,646.40 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
31,888,441.18 |
| Other Non-Current Assets |
9,299,183.00 |
| Sub-Total of Non-Current Assets |
668,996,868.12 |
| Total Assets |
2,821,058,459.40 |
| Short-Term Loans |
8,859,685.35 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,214,464.32 |
| Accounts Payable |
273,587,699.88 |
| Accounts Received In Advance |
1,098,282.54 |
| Employee Compensation Payable |
53,177,517.64 |
| Taxes Payable |
15,326,588.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
48,719,805.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
428,571.59 |
| Other Current Liabilities |
118,642,800.00 |
| Sub-Total of Current Liabilities |
1,093,374,003.02 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
48,751,456.78 |
| Total Liabilities |
1,142,125,459.80 |
| Paid-In Capital(Or Share Stock) |
239,991,649.00 |
| Capital Surplus |
1,376,321,079.70 |
| Surplus Reserve |
104,690,537.20 |
| LESS:Treasury Stock |
71,814,283.23 |
| Undistributed Profits |
89,308,716.66 |
| Minority Stockholder's Interest |
-57,064,699.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,735,997,699.33 |
| Owner's Equity（Stockholder's Equity） |
1,678,932,999.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,821,058,459.40 |
